Shanghai Xihua Scientific Co., Ltd.(Xihua) was established in 2015. The headquarters is located in the core area of the Pharmaceutical Valley in Zhangjiang Hi-Tech Park, Shanghai. We have subsidiaries Xihua PharmaTech, Xihua Clinical , Suzhou Xihua , Xihua Pharmaceuticals, Chuzhou Xihua, etc. Besides, Xihua holds Primera Analytical Solutions Corp.(U.S.) and TCM (U.S.) as well.
Shanghai Xihua PharmaTech Co., Ltd. (Xihua PharmaTech) is a wholly owned subsidiary of Shanghai Xihua Scientific Co., Ltd. Xihua PharmaTech have ever been providing services for many famous companies at home and abroad. And it is devoted to the research and development of poorly soluble drugs, sustained or controlled release drug product, complex dosage form, modified new drugs and innovative drugs. And Xihua PharmaTech is able to provide integrated service from product project, process route design, formulation and process development, scale-up manufacturing, process validation, and quality research to registration for API and drug product company.
Suzhou Xihua Scientific Co., Ltd. , which is a subsidiary company of Shanghai Xihua Scientific Co., Ltd. At present, Suzhou Xihua has SPF-Class Housing of laboratory for small animals and General Grade Laboratory for large animals, and laboratories for large and small molecule bioanalysis, furthermore, Biosafety Laboratory 2 (BL2) for large and small animals are under construction.
Shanghai Xihua Clinical Services Co., Ltd. (“Xihua Clinical”), which is a subsidiary company of Shanghai Xihua Scientific Co., Ltd. Xihua Clinical operates in both China and the United States, with offices in Shanghai, New Jersey.
Shanghai Xihua Pharmaceuticals Co., Ltd. (“Xihua Pharma”), which is a subsidiary company of Shanghai Xihua Scientific Co., Ltd.Xihua Pharma provides one-stop services from R&D to manufacturing of API and formulation (DP), analysis of large/small molecular and GCTP, and regulatory filing.
Primera Analytical Solutions, Xihua's subsidiary, provides analytical services for small/large molecules, cell & gene therapy products. Primera broadens Xinhua's capability in bioanalysis, pharmaceutical analysis, and clinical data statistical analysis in the United States.
TCM Groups, Inc. (“TCM”) was founded in 2003 and operates in both U.S. and China, which is a holding subsidiary of Shanghai Xihua Scientific Co., Ltd. We are a contract research organization (CRO) dedicated to providing clinical data management, statistical analysis and programming, medical writing, pharmacovigilance, and regulatory strategy services for global pharmaceutical companies.